Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Recursive Partitioning Analysis Demonstrating Risk Subsets for 8-Year Biochemical Relapse After Margin-Positive Radical Prostatectomy Without Adjuvant Hormone or Radiation Therapy.

Advances in radiation oncology·2021
Same author

Long-term outcome comparison for standard fractionation (>59 Gy) versus hyperfractionated (>45 Gy) radiotherapy plus concurrent chemotherapy for limited-stage small-cell lung cancer.

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology·2020
Same author

Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC).

Cancer medicine·2019
Same author

Pretreatment albumin may aid in patient selection for intrahepatic Y-90 microsphere transarterial radioembolization (TARE) for malignancies of the liver.

Journal of gastrointestinal oncology·2018
Same author

Radiotherapy-induced reactivation of neurotrophic human herpes viruses: Overview and management.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2017
Same author

Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy Alone.

Pathology oncology research : POR·2017

Related Experiment Video

Updated: Jun 26, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Helical tomotherapy for total lymphoid irradiation.

Kathryn W McCutchen1, John M Watkins, Paul Eberts

  • 1Department of Radiation Oncology, Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29425, USA.

Radiation Medicine
|January 10, 2009
PubMed
Summary

Total lymphoid irradiation (TLI) using helical tomotherapy offers precise radiation delivery for transplant patients. This advanced technique minimizes dose to healthy organs, improving patient tolerance and outcomes in cardiac transplant rejection.

More Related Videos

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Related Experiment Videos

Last Updated: Jun 26, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein
05:51

Computed Tomography (CT) Guided Implantation of a Totally Implantable Venous Access Port (TIVAP) through Subclavian Vein

Published on: January 13, 2026

Area of Science:

  • Radiation Oncology
  • Transplantation Immunology
  • Medical Physics

Background:

  • Total lymphoid irradiation (TLI) is a critical component in preparative regimens for transplantation and managing graft-versus-host disease.
  • Conventional linear accelerator-based TLI necessitates complex setups and delivers radiation indiscriminately to organs within the beam path.
  • Technological advancements are needed to improve precision and reduce toxicity associated with TLI.

Observation:

  • Megavoltage helical tomotherapy (MHT) offers a novel approach to TLI delivery with a continuously rotating fan beam.
  • MHT enables highly conformal target coverage and precise patient positioning using integrated megavoltage computed tomography (MVCT).
  • A case report details MHT-based TLI in an adult patient experiencing late-onset cardiac transplant rejection.

Findings:

  • Treatment planning with MHT allowed significant dose minimization to radiosensitive organs, including the spinal cord, kidneys, lungs, and intestinal compartment.
  • The patient tolerated MHT-based TLI well, experiencing no acute adverse effects.
  • This approach demonstrates the feasibility of precise TLI delivery for complex clinical scenarios.

Implications:

  • Helical tomotherapy represents a significant technological advance for TLI, enhancing treatment precision and patient safety.
  • MHT facilitates conformal radiotherapy, allowing for better sparing of organs at risk in transplantation protocols.
  • This case highlights the potential of MHT to improve the therapeutic ratio of TLI in managing transplant complications.